{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:08Z","timestamp":1794014828565,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005632.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000}}],"reference-count":281,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005632.pub4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:41:22Z","timestamp":1779799282000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Steroid avoidance or withdrawal for kidney transplant recipients"],"prefix":"10.1002","volume":"2026","author":[{"given":"Laia","family":"Oliveras","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Spain"},{"name":"Biomedical Research Institute (IDIBELL); Hospital Duran i Reynals; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Melilli","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Spain"},{"name":"Biomedical Research Institute (IDIBELL); Hospital Duran i Reynals; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M","family":"Cruzado","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Spain"},{"name":"Biomedical Research Institute (IDIBELL); Hospital Duran i Reynals; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi V","family":"Nagler","sequence":"additional","affiliation":[{"name":"Renal Division, Sector Metabolic and Cardiovascular Conditions; Ghent University Hospital; Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health; The University of Sydney; Sydney Australia"},{"name":"Westmead Applied Research Centre; The University of Sydney at Westmead; Westmead Australia"},{"name":"Department of Transplant and Renal Medicine; Westmead Hospital; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n; Hospital 12 de Octubre (imas12); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Montero","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Spain"},{"name":"Biomedical Research Institute (IDIBELL); Hospital Duran i Reynals; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"supported by Cochrane Kidney and Transplant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ndt\/gfae040","article-title":"A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS","volume":"39","author":"Stel","year":"2024","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"26","key":"10.1002\/14651858.CD005632.pub4-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Lenore","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Molecular & Cellular Endocrinology"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e061476","DOI":"10.1136\/bmjopen-2022-061476","article-title":"Metabolic adverse events associated with systemic corticosteroid therapy-a systematic review and meta-analysis","volume":"12","author":"Kulkarni","year":"2022","journal-title":"BMJ Open"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1097\/00007890-199912270-00009","article-title":"Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Steroid Withdrawal Study Group","volume":"68","author":"Ahsan","year":"1999","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S543","DOI":"10.1097\/00007890-199905150-00029","article-title":"Prednisone withdrawal in kidney transplant recipients on CSA\/MMF - a prospective randomized study [abstract no: 4]","volume":"67","author":"Matas","year":"1999","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1097\/01.tp.0000188300.26762.74","article-title":"Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus\/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study","volume":"80","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005632.pub4-BIB0008|cit8","first-page":"312","article-title":"Comparison of two steroid-free regimens - basiliximab\/tacrolimus and tacrolimus\/MMF - with tacrolimus\/MMF\/steroid therapy after renal transplantation [abstract no: 626]","volume":"3","author":"Vitko","year":"2003","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0009|cit9","unstructured":"Kramer BK Margreiter R Hoffmann U Wlodarcyzk Z Tyden G Senatorski G 1-year-follow-up of two steroid-free immunosuppressive regimens - basiliximab\/tacrolimus and tacrolimus\/MMF - compared to tacrolimus\/MMF\/steroids after renal transplantation [abstract no: 216] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.transproceed.2005.03.139","article-title":"Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens","volume":"37","author":"Kramer","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"Oct","key":"10.1002\/14651858.CD005632.pub4-BIB0011|cit11","first-page":"289A","article-title":"1-year-follow-up of two steroid-free immunosuppressive regimens - basiliximab\/tacrolimus and tacrolimus\/MMF - in comparison to tacrolimus\/MMF\/steroids after renal transplantation [abstract no: F-PO1026]","volume":"15","author":"Kramer","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1399-0012.2009.01162.x","article-title":"Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results","volume":"24","author":"Kramer","year":"2010","journal-title":"Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/TP.0b013e31825c1d6c","article-title":"Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial","volume":"94","author":"Kramer","year":"2012","journal-title":"Transplantation"},{"issue":"Nov","key":"10.1002\/14651858.CD005632.pub4-BIB0014|cit14","first-page":"9A","article-title":"Two steroid-free immunosuppressive regimens (basiliximab\/tacrolimus and tacrolimus\/MMF) in comparison to tacrolimus\/MMF\/steroid therapy after renal transplantation [abstract no: F-FC039]","volume":"14","author":"Kramer","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005632.pub4-BIB0015|cit15","first-page":"788","article-title":"Large, prospective study evaluating steroid-free immunosuppression with tacrolimus\/basiliximab and tacrolimus\/MMF compared with tacrolimus\/MMF\/steroids in renal transplantation [abstract no: W748]","volume":"18","author":"Klinger","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1681\/ASN.V82294","article-title":"Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study","volume":"8","author":"Hollander","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0017|cit17","first-page":"A276","article-title":"Late prednisone withdrawal in renal transplant patients [abstract]","volume":"11","author":"Hollander","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0018|cit18","first-page":"1911","article-title":"Late prednisone withdrawal in renal transplant patients [abstract no: A3323]","volume":"7","author":"Hollander","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0019|cit19","first-page":"79","article-title":"In vitro study: prediction of graft rejection after withdrawal of steroids","volume":"8","author":"Bouma","year":"1996","journal-title":"Transplantationsmedizin: Organ Der Deutschen Transplantationsgesellschaft"},{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/00007890-199611270-00008","article-title":"In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal","volume":"62","author":"Bouma","year":"1996","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Sundaram","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005632.pub2","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients","author":"Pascual","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD005632.pub4-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005632.pub3","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients","author":"Maria C","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0024|cit24","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological Expectations of Cochrane Intervention Reviews . Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0026|cit26","unstructured":"SONG Handbook Version 1.0; 2017 Available at https:\/\/songinitiative.org\/reports-and-publications\/"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0027|cit27","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0028|cit28","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0029|cit29","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"7414","key":"10.1002\/14651858.CD005632.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0032|cit32","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-14"},{"issue":"7650","key":"10.1002\/14651858.CD005632.pub4-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0035|cit35","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-15"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/ndt\/gfs146","article-title":"Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients","volume":"27","author":"Thierry","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00007890-201007272-00215","article-title":"Intensified dose of enteric-coated mycophenolate sodium (EC-MPS) for 6 weeks, in combination with anti-IL2r induction, cyclosporine micro-emulsion (CSA-ME) with or without steroids, in adult de novo low immunological risk kidney transplant recipients: final efficacy and safety results of a prospective multicenter randomized open-label study: DOMINOS study [abstract no: 433]","volume":"90","author":"Touchard","year":"2010","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005632.pub4-BIB0038|cit38","first-page":"515","article-title":"Multicenter, randomized, comparative, open-label study to evaluate efficacy and safety a combination of anti-IL2R, intensified dose of enteric-coated mycophenolate sodium (EC-MPS) for 6 weeks, ciclosporine micro-emulsion (CsA-ME), with or without steroids, in adult kidney de novo transplant recipients (TxR) [abstract no: 1679]","volume":"10","author":"Touchard","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0039|cit39","first-page":"232","article-title":"Intensified dose of enteric-coated mycophenolate sodium (EC-MPS) for steroids avoidance, in combination with ciclosporine micro-emulsion (CsA-ME): multicenter, randomized, open label, comparative study in de novo kidney transplantation (DOMINOS) [abstract no: P-557]","volume":"22","author":"Touchard","year":"2009","journal-title":"Transplant International"},{"issue":"Suppl S5","key":"10.1002\/14651858.CD005632.pub4-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/ajt.12266","article-title":"Three-year safety and efficacy outcomes in kidney transplant patients randomized to steroid avoidance or maintenance steroids with early intensified dosing of enteric-coated mycophenolate sodium: The INFINITY Study [abstract no: B1099]","volume":"13","author":"Thierry","year":"2013","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"171898","DOI":"10.1155\/2014\/171898","article-title":"Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the INFINITY study","volume":"2014","author":"Thierry","year":"2014","journal-title":"Journal of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.transproceed.2014.05.087","article-title":"A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids?","volume":"46","author":"Ponticelli","year":"2014","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/tri.12210","article-title":"Twelve-month outcomes from EVIDENCE trial (everolimus once-a-day regimen with cyclosporine versus corticosteroid elimination) in adult kidney transplant recipients [abstract no: O193]","volume":"26","author":"Carmellini","year":"2013","journal-title":"Transplant International"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/TP.0000000000004776","article-title":"Comparison of 2 immunosuppression minimization strategies in kidney transplantation: the ALLEGRO trial","volume":"108","author":"den Born","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1097\/TXD.0000000000000794","article-title":"Early steroid withdrawal compared with standard immunosuppression in kidney transplantation - interim analysis of the Amsterdam-Leiden-Groningen randomized controlled trial","volume":"4","author":"Sandwijk","year":"2018","journal-title":"Transplantation Direct"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005632.pub4-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/ajt.14918","article-title":"Early steroid withdrawal or tacrolimus minimization versus standard immunosuppression in renal transplant recipients: the ALLEGRO trial [abstract no: C71]","volume":"18","author":"Sanders","year":"2018","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/jcm10092005","article-title":"Clinical relevance of corticosteroid withdrawal on graft histological lesions in low-immunological-risk kidney transplant patients","volume":"10","author":"Hernandez","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/jcm10091934","article-title":"Impact of HLA mismatching on early subclinical inflammation in low-immunological-risk kidney transplant recipients","volume":"10","author":"Hernandez","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"iii390","DOI":"10.1093\/ndt\/gfx157.SP736","article-title":"CCR4 high CD4+ cell populations in kidney graft blood after steroid withdrawal: a prospective, randomized, controlled, parallel group study. Preliminary results [abstract]","volume":"32","author":"Alonso-Titos","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0050|cit50","first-page":"749","article-title":"Evolution of CCR4highCD4+ subpopulations in renal graft blood after steroid withdrawal: a prospective, randomized, controlled study in parallel groups. Preliminary results [abstract no: D116]","volume":"17","author":"Alonso-Titos","year":"2017","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/ajt.14306","article-title":"Steroid withdrawal and de novo donor-specific HLA antibodies in renal transplant patients: a prospective, randomized, controlled study in parallel groups. Preliminary results [abstract no: A10]","volume":"17","author":"Alonso-Titos","year":"2017","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"iii410","DOI":"10.1093\/ndt\/gfx158.SP792","article-title":"De novo donor-specific HLA antibodies after steroid withdrawal in kidney transplant recipients: a prospective, randomized, controlled, parallel group study. Preliminary results [abstract]","volume":"32","author":"Alonso-Titos","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1097\/01.tp.0000542857.44740.52","article-title":"Effect of steroid withdrawal on the appearance of de novo donor-specific HLA antibodies in kidney transplant recipients: A prospective, randomized, controlled, parallel group study. Preliminary results [abstract no: 423.11]","volume":"102","author":"Vazquez-Sanchez","year":"2018","journal-title":"Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1097\/01.tp.0000543500.81068.4a","article-title":"Analysis of CCR4high CD4+ in kidney graft blood after steroid withdrawal: a prospective, randomized, controlled, parallel group study. Preliminary results [abstract no: P.266]","volume":"102","author":"Vazquez-Sanchez","year":"2018","journal-title":"Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.tp.0000542626.78185.21","article-title":"Increase in proinflammatory CD14++CD16+ monocytes in samples from aspiration cytology compared with peripheral blood in kidney transplant patients with borderline rejection [abstract no: 322.1]","volume":"102","author":"Vazquez-Sanchez","year":"2018","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0056|cit56","first-page":"643","article-title":"Increase in proinflammatory CD14++CD16+ monocytes in samples from aspiration cytology compared with peripheral blood in kidney transplant patients with borderline rejection [abstract no: A140]","volume":"19","author":"Vazquez-Sanchez","year":"2019","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0057|cit57","unstructured":"Aswad S Zapanta R Wu L Bogaard T Asai P Khetan U Steroid withdrawal in living related kidney transplant patients receiving FK506 [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini, Italy 1998 394"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-6143.2004.00638.x","article-title":"Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial","volume":"5","author":"Vanrenterghem","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"Sept","key":"10.1002\/14651858.CD005632.pub4-BIB0059|cit59","first-page":"711A","article-title":"The influence of early steroid withdrawal on bone mineral density in renal transplant patients [abstract no: A3738]","volume":"11","author":"den Ham","year":"2000","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"Sept","key":"10.1002\/14651858.CD005632.pub4-BIB0060|cit60","first-page":"711A","article-title":"The influence of early steroid withdrawal on body composition in renal transplant patients [abstract no: A3737]","volume":"11","author":"den Ham","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005632.pub4-BIB0061|cit61","first-page":"920","article-title":"First, large, prospective study of a controlled withdrawal of steroids or MMF following three months of tacrolimus\/MMF\/steroid therapy [abstract no: A4809]","volume":"12","author":"Hooff","year":"2001","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0062|cit62","unstructured":"van Hooff JP; European Tacrolimus\/MMF Transplantation Study Group Effect of controlled steroid withdrawal on glucose levels in a tacrolimus-based immunosuppression regimen [abstract] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/s0041-1345(02)03032-4","article-title":"Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study","volume":"34","author":"Squifflet","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/s0041-1345(02)03082-8","article-title":"Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids","volume":"34","author":"Rigotti P; European Tacrolimus\/MMF Transplantation Study Group","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0065|cit65","first-page":"246","article-title":"Efficacy and safety of three months of tacrolimus\/steroids\/MMF followed by a controlled withdrawal of steroids or MMF: results of a large, prospective, multicentre trial [abstract no: 443]","volume":"1","author":"Salmela","year":"2001","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00147-002-0488-8","article-title":"The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients","volume":"16","author":"den Ham","year":"2003","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0067|cit67","unstructured":"van Hooff JP Salmela K Budde K Pascual J Rigotti P Lang P Long-term efficacy and safety of steroid-withdrawal in tacrolimus-treated patients: results of a long-term follow-up study in renal transplant recipients [abstract no: 99] 11th Congress of the European Society for Transplantation (ESOT); 2003 Sept 20-24; Venice, Italy 2003"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005632.pub4-BIB0068|cit68","first-page":"576","article-title":"Long-term efficacy and safety of steroid-withdrawal in tacrolimus treated renal transplant recipients: results of a 3 year follow-up [abstract no: 1524]","volume":"4","author":"Pascual","year":"2004","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0069|cit69","unstructured":"Pascual J Vanrenterghem Y van Hooff JP Squifflet JP Salmela K Rigotti P Safe withdrawal of MMF or steroids following 3-months of tacrolimus triple therapy: results of a large, prospective, multicentre study [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.tp.0000225806.80890.5e","article-title":"Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant","volume":"82","author":"Pascual","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0071|cit71","first-page":"190","article-title":"Reduction of high cholesterol levels by early withdrawal of steroids from a tacrolimus-based triple regimen [abstract no: 206]","volume":"2","author":"Jindal","year":"2002","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0072|cit72","unstructured":"Budde K Salmela K Pascual J Rigotti P; THOMAS Follow-up Study Group Steroid-withdrawal in tacrolimus-treated renal transplant recipients: results of a 3-year follow-up study [abstract] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/s0041-1345(02)02987-1","article-title":"Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation","volume":"34","author":"Boots","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 3","key":"10.1002\/14651858.CD005632.pub4-BIB0074|cit74","first-page":"1865","article-title":"A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group","volume":"19","author":"MacDonald","year":"1987","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0075|cit75","first-page":"998","article-title":"The requirements for maintenance steroids in cyclosporine-treated renal transplant recipients [abstract]","volume":"25","author":"Canadian Transplant Study Group","year":"1984","journal-title":"Kidney International"},{"issue":"4 Suppl 1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0076|cit76","first-page":"2490","article-title":"The requirements for maintenance steroids in cyclosporine-treated renal transplant recipients","volume":"15","author":"Stiller","year":"1983","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.transproceed.2014.11.063","article-title":"Long-term study of steroid avoidance in renal transplant patients: a single-center experience","volume":"47","author":"Nagib","year":"2015","journal-title":"Transplant Proceedings"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0078|cit78","first-page":"100","article-title":"Long term study of steroid avoidance in renal transplant patients: a single center experience [abstract]","volume":"12","author":"Nagib","year":"2014","journal-title":"Experimental & Clinical Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0079|cit79","first-page":"2669","article-title":"Cyclosporine therapy with or without steroids in cadaveric kidney transplantation - a prospective randomized one-center study","volume":"17","author":"Albert","year":"1985","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0080|cit80","first-page":"708","article-title":"Cyclosporin A (Cy A) therapy with or without steroids in cadaveric kidney transplantation. A prospective randomized one-center study [abstract]","volume":"28","author":"Albert","year":"1985","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0081|cit81","first-page":"645","article-title":"Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group","volume":"147","author":"Sinclair","year":"1992","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD005632.pub4-BIB0082|cit82","first-page":"990","article-title":"Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients","volume":"23","author":"Gulanikar","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00355456","article-title":"Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression","volume":"3","author":"Isoniemi","year":"1990","journal-title":"Transplant International"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/00007890-199303000-00008","article-title":"Long-term consequences of different immunosuppressive regimens for renal allografts. [Erratum in: Transplantation 1998 Sep 15;66(5):678]","volume":"55","author":"Isoniemi","year":"1993","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ki.1992.21","article-title":"Histopathological findings in well-functioning, long-term renal allografts","volume":"41","author":"Isoniemi","year":"1992","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00335513","article-title":"Renal allograft immunosuppression. III. Triple therapy versus three different combinations of double drug treatment: two year results in kidney transplant patients","volume":"4","author":"Isoniemi","year":"1991","journal-title":"Transplant International"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1399-0012.1991.tb00154.x","article-title":"Renal allograft immunosuppression V: Glucose intolerance occurring in different immunosuppressive treatments","volume":"5","author":"Isoniemi","year":"1991","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/tri.1992.5.s1.6","article-title":"Late histopathological findings in renal allografts with four immunosuppressive regimens","volume":"5 Suppl 1","author":"Isoniemi","year":"1992","journal-title":"Transplant International"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00335332","article-title":"Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations","volume":"4","author":"Isoniemi","year":"1991","journal-title":"Transplant International"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD005632.pub4-BIB0090|cit90","first-page":"1029","article-title":"Lipid profiles with triple drug immunosuppressive therapy and with double drug combinations after renal transplantation and stable graft function","volume":"23","author":"Isoniemi","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00335336","article-title":"Renal allograft immunosuppression. VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts","volume":"4","author":"Isoniemi","year":"1991","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0092|cit92","first-page":"1365","article-title":"Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results","volume":"22","author":"Isoniemi","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0093|cit93","first-page":"2716","article-title":"Chronic rejection of renal allografts with four immunosuppressive regimens","volume":"24","author":"Isoniemi","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0094|cit94","first-page":"47","article-title":"Prospective trials with cyclosporine monotherapy in cadaver renal transplantation","volume":"3","author":"Johnson","year":"1990","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0095|cit95","first-page":"S81","article-title":"Improved patient and graft survival using cyclosporin A in cadaver renal transplantation","volume":"54 Suppl","author":"Johnson","year":"1985","journal-title":"Ulster Medical Journal"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD005632.pub4-BIB0096|cit96","first-page":"1581","article-title":"Cadaver renal transplantation without maintenance steroids","volume":"21","author":"Johnson","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0097|cit97","unstructured":"Kacar S Gurkan A Karaoglan M Akman F Varilsuha C Karaca C Steroid withdrawal protocol in renal transplantation [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 401"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0098|cit98","first-page":"397","article-title":"Rapid steroid withdrawal versus standard steroid treatment in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in kidney transplantation: a 2-year follow-up [abstract no: 1029]","volume":"2","author":"Kim","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"9028","key":"10.1002\/14651858.CD005632.pub4-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s0140-6736(96)02510-x","article-title":"Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression","volume":"348","author":"Ratcliffe","year":"1996","journal-title":"Lancet"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD005632.pub4-BIB0100|cit100","first-page":"590","article-title":"Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression","volume":"25","author":"Ratcliffe","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"11","key":"10.1002\/14651858.CD005632.pub4-BIB0101|cit101","first-page":"1672","article-title":"Effect of steroid withdrawal on graft function in renal transplant recipients [abstract]","volume":"9","author":"Dudley","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0102|cit102","first-page":"518","article-title":"Renal transplant function after steroid withdrawal from triple immunosuppression [abstract]","volume":"4","author":"Newstead","year":"1989","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00007890-199002000-00020","article-title":"A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients","volume":"49","author":"Schulak","year":"1990","journal-title":"Transplantation"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD005632.pub4-BIB0104|cit104","first-page":"1709","article-title":"Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine","volume":"21","author":"Schulak","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00007890-199201000-00007","article-title":"Withdrawal of steroids after renal transplantation--clinical predictors of outcome","volume":"53","author":"Hricik","year":"1992","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00007890-199001000-00051","article-title":"Association of the absence of steroid therapy with increased cyclosporine blood levels in renal transplant recipients","volume":"49","author":"Hricik","year":"1990","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s0272-6386(12)80095-3","article-title":"Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia","volume":"18","author":"Hricik","year":"1991","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/01.asn.0000013298.11876.bf","article-title":"Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study","volume":"13","author":"Smak Gregoor","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1097\/00007890-199904150-00959","article-title":"Withdrawal of cyclosporine or prednisone in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone: a randomized study [abstract no: 935]","volume":"67","author":"Sevaux","year":"1999","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005632.pub4-BIB0110|cit110","first-page":"920A","article-title":"Discontinuation of cyclosporine or prednisone 6 months after kidney transplantation: a randomized trial [abstract no: A4808]","volume":"12","author":"Van Gelder","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005632.pub4-BIB0111|cit111","first-page":"217","article-title":"Long-term results of a randomized, prospective study after withdrawal of cyclosporine or prednisone in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone [abstract no: 257]","volume":"3","author":"Smak Gregoor","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/00007890-199911270-00028","article-title":"Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients","volume":"68","author":"Smak Gregoor","year":"1999","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0113|cit113","first-page":"246","article-title":"A prospective randomised study of withdrawal of cyclosporine or prednisone in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone: 18 months follow-up data [abstract no: 441]","volume":"1","author":"Smak Gregoor","year":"2001","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.TP.0000442774.46133.71","article-title":"15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation","volume":"98","author":"Roodnat","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0115|cit115","first-page":"83","article-title":"15 year follow-up of a multicentre, randomised, calcineurin inhibitor (CNI) withdrawal study in kidney transplantation [abstract no: BO156]","volume":"26","author":"Roodnat","year":"2013","journal-title":"Transplant International"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/s0041-1345(02)02983-4","article-title":"Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil","volume":"34","author":"Sola","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/s1001-9294(09)60047-x","article-title":"Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation","volume":"23","author":"Zhu","year":"2008","journal-title":"Chinese Medical Sciences Journal"},{"issue":"9 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.tp.0000885480.32306.53","article-title":"Steroid avoidance and progression of interstitial fibrosis assessed by automated quantification after kidney kransplantation: a multicenter randomized non-inferiority trial (the ASTRONEF study) [abstract no: 215.14]","volume":"106","author":"Ville","year":"2022","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0041-1345(00)02400-3","article-title":"Successful withdrawal of steroid after renal transplantation","volume":"33","author":"Boletis","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0120|cit120","first-page":"312","article-title":"Steroids withdrawal in renal transplant recipients: a randomized controlled study [abstract no: T447]","volume":"17","author":"Boletis","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Boletis JN Konstadinidou I Chelioti H Theodoropoulou H Avdikou K Kostakis A Successful withdrawal of steroids after renal transplantation [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1016\/S0041-1345(00)02400-3"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/00007890-200212270-00011","article-title":"Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study","volume":"74","author":"Boots","year":"2002","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD005632.pub4-BIB0123|cit123","first-page":"878A","article-title":"Early steroid withdrawal in renal transplant recipients with tacrolimus double therapy immunosuppression [abstract no: A4594]","volume":"12","author":"Boots","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Boots JM Christaiaans MH van Duijnhoven EM Van Suylen RJ van Hooff JP Early steroid withdrawal in renal transplant recipients with tacrolimus dual therapy [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002","DOI":"10.1097\/00007890-200212270-00011"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/s0041-1345(02)02988-3","article-title":"Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study","volume":"34","author":"Boots","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0126|cit126","first-page":"172","article-title":"Double-blind, placebo-controlled, 3 year study of steroid withdrawal using a neoral and mycophenolate mofetil (MMF)-based immunosuppressive regimen in primary renal transplant recipients [abstract no: 137]","volume":"2","author":"Francos","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/00007890-200004271-00426","article-title":"A double-blind, placebo-controlled, three-year study of steroid withdrawal using a neoral-based immunosuppressive regimen in primary renal transplant recipients: an interim report [abstract no: 426]","volume":"69","author":"Burke","year":"2000","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0128|cit128","first-page":"296","article-title":"Double-blind, placebo-controlled trial of steroid withdrawal in kidney transplant recipients with a cyclosporine\/mycophenolate regimen-three year follow up [abstract no: 639]","volume":"1","author":"Burke","year":"2001","journal-title":"American Journal of Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1600-6143.2006.01557.x","article-title":"Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density","volume":"6","author":"Farmer","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0130|cit130","first-page":"190","article-title":"What is the value of short synacthen tests in predicting the ease of steroid withdrawal in renal transplant recipients? A randomised controlled trial [abstract no: 217]","volume":"1","author":"Farmer","year":"2001","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0131|cit131","first-page":"84","article-title":"12-month results of a prospective, randomized trial of steroid avoidance, steroid withdrawal or standard steroids in de novo renal transplant patients receiving cyclosporine, enteric-coated mycophenolate sodium (EC-MPS, myfortic\u00ae) and basiliximab [abstract no: 54]","volume":"6","author":"Schena","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0132|cit132","first-page":"A214","article-title":"Preliminary results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS), basiliximab, and neoral C-2 comparing two investigational steroid regimens (without steroids or short-term use of steroids) with standard steroid treatment in de novo kidney recipients [abstract no: T-PO50027]","volume":"10","author":"Walker","year":"2005","journal-title":"Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients [Erratum in: Am J Transplant.2008 May;8(5):1080]","volume":"8","author":"Vincenti","year":"2008","journal-title":"American Journal of Transplantation"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005632.pub4-BIB0134|cit134","first-page":"562A","article-title":"Comparison of metabolic parameters in renal transplant patients randomized to steroid avoidance, steroid withdrawal or standard steroids with a 12-month, randomized, multicenter trial [abstract no: F-PO1076]","volume":"17","author":"Vincenti","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005632.pub4-BIB0135|cit135","first-page":"69A","article-title":"Renal function and rejection incidence in de novo renal transplant patients randomized to steroid avoidance, steroid withdrawal or standard steroids [abstract no: F-FC153]","volume":"17","author":"Schena","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0136|cit136","first-page":"A24","article-title":"Renal functions and rejection incidence in de novo renal transplant patients randomised to steroid avoidance, steroid withdrawal or standard steroids [abstract]","volume":"85","author":"Chadban","year":"2007","journal-title":"Immunology & Cell Biology"},{"issue":"Oct","key":"10.1002\/14651858.CD005632.pub4-BIB0137|cit137","first-page":"236A","article-title":"3 months interim results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS, Myfortic\u00ae), basiliximab, and neoral C-2 comparing different steroid protocols in de novo kidney recipients [abstract no: TH-PO544]","volume":"16","author":"Vincenti","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0138|cit138","unstructured":"Walker R Chadban S Russ G Comparison of metabolic parameters in renal transplant patients randomised to steroid avoidance, steroid withdrawal or standard steroids within a 12 month randomised multicentre trial [abstract] Transplantation Society of Australia & New Zealand (TSANZ). 25th Annual Scientific Meeting; 2007 Mar 28-30; Canberra (ACT) 2007 32"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0139|cit139","unstructured":"Walker R Campbell S Chadban S Kanellis J Pilmore H Russ G Preliminary results of a 12-month study with enteric-coated mycophenolate sodium (EC-MPS), basiliximab, and neoral C-2 comparing a regimen without steroids or short-term use of steroids with standard steroid treatment in de novo kidney recipients [abstract no: 34] Transplantation Society of Australia & New Zealand (TSANZ). 24th Annual Scientific Meeting; 2006 Mar 29-31; Canberra, Australia 2006 52"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0140|cit140","first-page":"548","article-title":"Preliminary 3-month results comparing immunosuppressive regimens of enteric-coated mycophenolate sodium (EC-MPS) without steroids vs short-term use of steroids vs standard steroid treatment including basiliximab, and neoral C-2 in de novo kidney recipients [abstract no: 1542]","volume":"5","author":"Vincenti","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0141|cit141","first-page":"483","article-title":"Metabolic effects of steroid avoidance or early steroid withdrawal: 12-month results of a randomized trial in de novo renal transplant patients receiving cyclosporine, enteric-coated mycophenolate sodium (EC-MPS) and basiliximab [abstract no: 1232]","volume":"6","author":"Vincenti","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"10063","key":"10.1002\/14651858.CD005632.pub4-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ebiom.2018.07.017","article-title":"BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation: results from a large multi-centre study","volume":"34","author":"Blazquez-Navarro","year":"2018","journal-title":"EBioMedicine"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0144|cit144","first-page":"1B","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation: an open label multicentre, randomized controlled trial [abstract no: HI-OR03]","volume":"27","author":"Hugo","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ndt\/gfad130","article-title":"Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study)","volume":"39","author":"Stumpf","year":"2024","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"19594","DOI":"10.1038\/s41598-020-76607-z","article-title":"The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation","volume":"10","author":"Bajda","year":"2020","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/TP.0b013e3181b0f92f","article-title":"Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation","volume":"88","author":"Jankowska-Gan","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1399-0012.2004.00298.x","article-title":"Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies","volume":"19","author":"Kumar","year":"2005","journal-title":"Clinical Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/01.tp.0000203558.34739.c6","article-title":"Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years","volume":"81","author":"Kumar","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0150|cit150","first-page":"570","article-title":"Basiliximab induction in African American recipients (AA) of cadaver kidneys (CAD) facilitates steroid avoidance, reduces acute rejection (AR) and prolongs survival [abstract no: 1627]","volume":"5","author":"Kumar","year":"2005","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0151|cit151","unstructured":"Kumar MS Hahn J Adams C Fa K Fyfe B Damask A Steroid avoidance (SA) in kidney transplant recipients treated with simulect (BMAB), neoral (CSA) and cellcept (MMF)-a randomized prospective controlled clinical trial [abstract no: 2440] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0152|cit152","first-page":"393","article-title":"Steroid avoidance (SA) in kidney transplant recipients treated with simulect (BMAB), neoral (CSA) and cellcept (MMF) - a randomized prospective controlled clinical trial [abstract]","volume":"2","author":"Kumar","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005632.pub4-BIB0153|cit153","first-page":"480","article-title":"The predictive value of subclinical rejection in a steroid free immunosuppressive regimen [abstract no: 1282]","volume":"3","author":"Fa","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0154|cit154","first-page":"171","article-title":"Value of one month protocol biopsies combined with a molecular analysis in predicting efficacy of rapid steroid withdrawal after renal transplantation [abstract no: 132]","volume":"2","author":"Fa","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.surg.2004.10.013","article-title":"Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety","volume":"137","author":"Laftavi","year":"2005","journal-title":"Surgery"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005632.pub4-BIB0156|cit156","first-page":"478","article-title":"Induction immunosuppression for renal transplantation using thymoglobulin, FK506 and mycophenolate mofetil allows for safe steroid withdrawal and eliminates the need for early protocol biopsies [abstract no: 1271]","volume":"3","author":"Pankewyez","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005632.pub4-BIB0157|cit157","first-page":"579","article-title":"The clinical benefits of early steroid withdrawal (7 days) and utility of protocol biopsies at 1, 6 and 12 months in guiding steroid-free immunosuppressive therapy after renal transplantation [abstract no: 1534]","volume":"4","author":"Pankewycz","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0158|cit158","first-page":"288","article-title":"Steroid withdrawal is associated with more chronic allograft nephropathy (CAN) following kidney transplantation [abstract no: 518]","volume":"5","author":"Laftavi","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00007890-200407271-00242","article-title":"The significance of protocol biopsy in immunominimization protocol: a prospective study of steroid withdrawal [abstract no: O229]","volume":"78","author":"Laftavi","year":"2004","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1097\/00007890-199904150-00956","article-title":"A comparison of two corticosteroid regimens in kidney transplanted patients treated with ATG\/OKT3 induction, mycophenolate mofetil (MMF) and cyclosporine A (CyA) for prevention of acute allograft rejection. 12 months results of a double-blind, randomized, multi-center study [abstract no: 932]","volume":"67","author":"Lebranchu Y; M55002 Study Group","year":"1999","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD005632.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00007890-199806270-00439","article-title":"A randomized, double-blind, multi-center trial comparing two corticosteroid regimens in combination with mycophenolate mofetil (MMF) and cyslosporine (CYA) in renal transplant recipients [abstract no: 420]","volume":"65","author":"Hene RJ; M55002 Study Group","year":"1998","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/s0041-1345(99)00327-9","article-title":"Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study","volume":"31","author":"Puig i Mari","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/s0041-1345(00)01251-3","article-title":"Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients","volume":"32","author":"Nowacka-Cieciura","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0041-1345(00)02475-1","article-title":"Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients","volume":"33","author":"Nowacka-Cieciura","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0166|cit166","doi-asserted-by":"crossref","unstructured":"Nowacka-Cieciura E Durlik M Cieciura T Talalaj M Kukula K Lewadowska D Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients [abstract no: P0568W] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sept 1; Rome, Italy 2000","DOI":"10.1016\/S0041-1345(00)02475-1"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/s0041-1345(01)02846-9","article-title":"Steroid withdrawal after renal transplantation--risks and benefits","volume":"34","author":"Nowacka-Cieciura","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/s0041-1345(01)02847-0","article-title":"Elevated serum immunoglobulins after steroid withdrawal in renal allograft recipients","volume":"34","author":"Nowacka-Cieciura","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s0041-1345(99)00992-6","article-title":"Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group","volume":"32","author":"Lebranchu","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0041-1345(98)01522-x","article-title":"Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group","volume":"31","author":"Lebranchu","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/ndt\/15.7.1041","article-title":"Withdrawal of steroids from triple-drug therapy in kidney transplant patients","volume":"15","author":"Matl","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0172|cit172","unstructured":"Matl I Lacha J Lodererova A Simova M Vitko S Withdrawal of steroids from triple drug therapy in renal transplant patients [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini, Italy 1998 351"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0173|cit173","first-page":"115","article-title":"Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation","volume":"139","author":"Matl","year":"2000","journal-title":"Casopis Lekaru Ceskych"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.transproceed.2004.11.033","article-title":"A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine","volume":"37","author":"Montagnino","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00007890-200407271-00445","article-title":"A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine [abstract no: O432]","volume":"78","author":"Ponticelli","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/ndt\/gfm621","article-title":"A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine","volume":"23","author":"Montagnino","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00007890-198704000-00010","article-title":"A controlled trial of steroids in cyclosporine-treated renal transplant recipients","volume":"43","author":"Griffin","year":"1987","journal-title":"Transplantation"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD005632.pub4-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/s0022-3476(87)80050-1","article-title":"Renal transplantation without steroids","volume":"111","author":"Salaman","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"1 II","key":"10.1002\/14651858.CD005632.pub4-BIB0179|cit179","first-page":"1289","article-title":"Low-dose steroids do not augment cyclosporine immunosuppression but do diminish cyclosporine nephrotoxicity","volume":"17","author":"Nott","year":"1985","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0180|cit180","first-page":"797","article-title":"Renal transplantation without steroids: a controlled clinical trial","volume":"18","author":"Griffin","year":"1986","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1399-0012.2005.00430.x","article-title":"Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine","volume":"20","author":"Pelletier","year":"2006","journal-title":"Clinical Transplantation"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/00007890-200004271-00573","article-title":"Randomized, prospective trial of prednisone withdrawal in stable renal transplant recipients [abstract no: 573]","volume":"69","author":"Pelletier","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"E113","DOI":"10.1111\/j.1399-0012.2010.01344.x","article-title":"Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients","volume":"25","author":"Ing","year":"2011","journal-title":"Clinical Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0184|cit184","first-page":"310","article-title":"Bone mineral density changes in a prospective, randomized trial of steroid withdrawal in kidney transplant recipients [abstract no: 621]","volume":"7","author":"Ing","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005632.pub4-BIB0185|cit185","first-page":"298","article-title":"Five year follow-up after steroid withdrawal demonstrates no evidence of worsening renal function [abstract no: 510]","volume":"4","author":"Akin","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ekir.2018.07.009","article-title":"Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus","volume":"3","author":"Torres","year":"2018","journal-title":"KI Reports"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1034\/j.1600-6143.2003.00005.x","article-title":"Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil","volume":"3","author":"Vincenti","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/00007890-200004271-00083","article-title":"Rapid steroid withdrawal versus standard steroid treatment in patients treated with simulect, neoral, and cellcept for the prevention of acute rejection in renal transplantation: a multicenter, randomized trial [abstract]","volume":"69","author":"Vincenti","year":"2000","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0041-1345(00)02308-3","article-title":"Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation","volume":"33","author":"Vincenti","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/00007890-199904150-00609","article-title":"A multicenter randomized trial of rapid steroid withdrawal vs standard steroid treatment in patients treated with Simulect, Neoral and Cellcept for the prevention of acute rejection in renal transplantation [abstract no: 583]","volume":"67","author":"Vincenti","year":"1999","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0191|cit191","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/01.TP.0000076096.45542.1B","article-title":"Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation","volume":"76","author":"Topp","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0192|cit192","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1046\/j.1523-1755.2003.00038.x","article-title":"Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients","volume":"63","author":"Painter","year":"2003","journal-title":"Kidney International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0193|cit193","first-page":"177","article-title":"A randomized, double-blind placebo controlled trial of early corticosteroid cessation versus chronic corticosteroids: three year results [abstract no: 326]","volume":"6","author":"Woodle ES; Astellas Steroid Withdrawal Study Group","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0194|cit194","first-page":"540","article-title":"A randomized, double blinded, placebo controlled trial of early corticosteroid cessation versus chronic corticosteroid maintenance therapy [abstract no: 1511]","volume":"5","author":"Woodle ES; Fujisawa Steroid Withdrawal Study Group","year":"2005","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0195|cit195","doi-asserted-by":"crossref","unstructured":"Woodle ES; Fujisawa Steroid Withdrawal Study Group A prospective, randomized, double blind, placebo controlled multicenter study of early (7 day) corticosteroid cessation vs. long term low dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction in renal transplant recipients [abstract] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004","DOI":"10.1097\/00007890-200407271-01228"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005632.pub4-BIB0196|cit196","first-page":"198","article-title":"A prospective, randomized, double blind, multicenter trial of early (7 day) corticosteroid cessation vs long term low dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction [abstract no: 183]","volume":"3","author":"Woodle ES; Fujisawa Steroid Withdrawal Study Group","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0197|cit197","first-page":"457","article-title":"A prospective, randomized, double blind multicenter study of early (7 day) corticosteroid cessation vs. long term low dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction in renal transplant recipients [abstract no: P732]","volume":"78","author":"Woodle ES; Fujisawa Steroid Withdrawal Study Group","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0198|cit198","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.transproceed.2004.12.083","article-title":"A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report","volume":"37","author":"Woodle ES; Fujisawa Corticosteroid Withdrawal Study Group","year":"2005","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0199|cit199","unstructured":"Woodle ES; Astellas Steroid Withdrawal Study Group A randomized double blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: four year results [abstract no: 1704] American Transplant Congress; 2007 May 5-9; San Francisco (CA) 2007"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0200|cit200","first-page":"300","article-title":"A randomized double blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: five year results [abstract no: 453]","volume":"8","author":"Woodle ES; Astellas Steroid Withdrawal Study Group","year":"2008","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0201|cit201","first-page":"178","article-title":"Characteristics of rejection in renal allografts following early corticosteroid withdrawal in a randomized controlled clinical trial: results of 3 year followup [abstract no: 330]","volume":"6","author":"Gaber","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005632.pub4-BIB0202|cit202","first-page":"578","article-title":"A prospective, randomized, double blind multicenter study of early (7 day) corticosteroid cessation vs. long term low dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction in renal transplant recipients [abstract no: 1528]","volume":"4","author":"Woodle ES; Fujisawa Steroid Withdrawal Study Group","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.tp.0000331958.42040.3b","article-title":"A multicenter, randomized, double blind, placebo-controlled trial of early corticosteroid cessation: final five year report [abstract no: 863]","volume":"86","author":"Woodle","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0204|cit204","first-page":"176","article-title":"African Americans experience different risks and benefits from early corticosteroid withdrawal than non-African Americans: results from a three year, double blind, randomized, placebo controlled trial [abstract no: 325]","volume":"6","author":"Woodle","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0205|cit205","first-page":"163","article-title":"Long term effects of early corticosteroid withdrawal and chronic corticosteroid therapy on posttransplant weight gain [abstract no: 287]","volume":"6","author":"Woodle","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0206|cit206","first-page":"353","article-title":"Comparison of T cell depleting and non-T cell depleting antibody induction therapy for early corticosteroid withdrawal regimens [abstract no: 849]","volume":"6","author":"Woodle","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0207|cit207","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Annals of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1600-6143.2012.04327.x","article-title":"Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study","volume":"13","author":"Shihab","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0209|cit209","first-page":"318","article-title":"Leukopenia limits mycophenolic mofetil dosing following early corticosteroid withdrawal: results from a randomized double-blinded placebo controlled trial [abstract no: 747]","volume":"6","author":"Shihab","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0210|cit210","first-page":"180","article-title":"Effect of corticosteroid withdrawal on tacrolimus blood trough levels and dosing: results from a randomized double-blind placebo controlled trial [abstract no: 336]","volume":"6","author":"Shihab","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0211|cit211","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/ajt.13247","article-title":"New-onset diabetes after transplantation: results from a double-blind early corticosteroid withdrawal trial","volume":"15","author":"Pirsch","year":"2015","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0212|cit212","first-page":"355","article-title":"Effect of steroid withdrawal on new onset diabetes after transplant: results of a randomized double-blind placebo controlled trial [abstract no: 856]","volume":"6","author":"Pirsch","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/FTD.0000000000000125","article-title":"Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation","volume":"37","author":"Lin","year":"2015","journal-title":"Therapeutic Drug Monitoring"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0214|cit214","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/TP.0b013e3182777efb","article-title":"Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal","volume":"95","author":"Gaber","year":"2013","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0215|cit215","first-page":"257","article-title":"Multivariate analysis of risk factors for acute rejection with early (7 day) corticosteroid withdrawal: results from a randomized, double blind, placebo-controlled trial [abstract no: 567]","volume":"6","author":"Alloway","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0216|cit216","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jamasurg.2020.6929","article-title":"Early corticosteroid cessation vs long-term corticosteroid therapy in kidney transplant recipients: long-term outcomes of a randomized clinical trial","volume":"156","author":"Woodle","year":"2021","journal-title":"JAMA Surgery"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0217|cit217","first-page":"402","article-title":"Fifteen year outcomes in the Astellas double blind randomized controlled trial (RCT) comparing early corticosteroid withdrawal (CSWD) and long-term corticosteroid therapy continuation (CCS) in kidney transplantation [abstract]","volume":"19","author":"Woodle","year":"2019","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000413101","article-title":"Ciclosporin alone or associated with steroid for immunosuppression of cadaveric renal transplants?","volume":"51","author":"De Vecchi","year":"1986","journal-title":"Contributions to Nephrology"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0012.1987.tb00966.x","article-title":"Ciclosporin alone or combined with steroid in the treatment of cadaveric renal transplant recipients","volume":"1","author":"De Vecchi","year":"1987","journal-title":"Clinical Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0220|cit220","first-page":"394","article-title":"Need for steroid in cyclosporine (Cy) treated cadaveric renal transplant recipients (pts) [abstract]","volume":"28","author":"De Vecchi","year":"1985","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0221|cit221","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1432-2277.2009.00971.x","article-title":"Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction","volume":"23","author":"Cantarovich","year":"2010","journal-title":"Transplant International"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/tri.12247","article-title":"Corticosteroid avoidance in adult kidney transplant recipients receiving ATG-F: 5 years results of a prospective and randomized study [abstract no: O35]","volume":"26","author":"Cantarovich","year":"2013","journal-title":"Transplant International"},{"issue":"11","key":"10.1002\/14651858.CD005632.pub4-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1111\/ajt.12866","article-title":"Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study","volume":"14","author":"Cantarovich","year":"2014","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0224|cit224","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/tri.12214","article-title":"Corticosteroid avoidance in adult kidney transplant recipients receiving ATG Fresenius induction: 5 years results of a prospective and randomized study [abstract no: P497]","volume":"26","author":"Albano","year":"2013","journal-title":"Transplant International"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0225|cit225","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/01.tp.0000255683.66156.d3","article-title":"Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids","volume":"83","author":"Louis","year":"2007","journal-title":"Transplantation"},{"issue":"Suppl S5","key":"10.1002\/14651858.CD005632.pub4-BIB0226|cit226","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ajt.12265","article-title":"Steroid avoidance in adult kidney transplant recipients: 5-year results of a prospective and randomized multicenter study [abstract no: 234]","volume":"13","author":"Cantarovich","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.tp.0000332094.42452.1d","article-title":"Steroid avoidance after renal transplantation: results of a prospective and randomized trial using Fresenius ATG [abstract no: 711]","volume":"86","author":"Cantarovich","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005632.pub4-BIB0228|cit228","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-6143.2010.03107.x","article-title":"Acute renal rejections are increased in the absence of corticosteroids but are not detrimental at one year in the context of ATG induction [abstract no: 515]","volume":"10","author":"Cantarovich D; FRANCIA Study Group","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0229|cit229","first-page":"141","article-title":"ATG-Fresenius induction and immunosuppression without steroids following renal transplantation: a prospective and randomized study [abstract no: P189]","volume":"20","author":"Cantarovich D; FRANCIA French Study Group","year":"2007","journal-title":"Transplant International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0230|cit230","first-page":"15-6","article-title":"Impact of steroid-free immunosuppression on interstitial fibrosis quantified by automated digital analysis: results of a prospective, randomized, multicentre phase IV study [abstract no: OS031]","volume":"32","author":"Cantarovich","year":"2019","journal-title":"Transplant International"},{"issue":"3 Suppl 3","key":"10.1002\/14651858.CD005632.pub4-BIB0231|cit231","first-page":"121","article-title":"Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine","volume":"20","author":"Maiorca","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0232|cit232","first-page":"139","article-title":"Controlled randomised trial of methylprednisolone withdrawal at the sixth month in renal transplant recipients treated with cyclosporin [abstract]","volume":"1","author":"Cristinelli","year":"1986","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1 Pt 3","key":"10.1002\/14651858.CD005632.pub4-BIB0233|cit233","first-page":"2021","article-title":"Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine","volume":"19","author":"Cristinelli","year":"1987","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000413102","article-title":"Controlled study of steroid withdrawal after 6 months in renal transplant patients treated with ciclosporin","volume":"51","author":"Cristinelli","year":"1986","journal-title":"Contributions to Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0235|cit235","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1681\/ASN.V12102163","article-title":"Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation","volume":"12","author":"Montagnino","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0236|cit236","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1681\/ASN.V84638","article-title":"A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe)","volume":"8","author":"Ponticelli","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0237|cit237","first-page":"A250","article-title":"Long-term results of a randomized trial of 3 cyclosporine (CSA) regimens in cadaveric kidney allografts (TXC) [abstract]","volume":"15","author":"Tarantino","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0238|cit238","unstructured":"Tarantino A; Italian Multicentre Study Group for Renal Transplantation (SIMTRe) Is cylosporine (CsA, Sandimmun) monotherapy an effective and safe immunosuppressant in renal transplant recipients? [Abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (ILL) 1997 128"},{"issue":"9268","key":"10.1002\/14651858.CD005632.pub4-BIB0239|cit239","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/s0140-6736(00)04766-8","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Goffin","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0240|cit240","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/s0041-1345(98)00407-2","article-title":"A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: results at 7 years","volume":"30","author":"Tarantino","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0241|cit241","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/s0041-1345(97)83775-x","article-title":"A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe)","volume":"29","author":"Ponticelli","year":"1997","journal-title":"Transplantation Proceedings"},{"issue":"9268","key":"10.1002\/14651858.CD005632.pub4-BIB0242|cit242","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(00)04765-6","article-title":"Osteoporosis after organ transplantation","volume":"357","author":"Ponticelli","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0243|cit243","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00007890-199702150-00009","article-title":"Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study","volume":"63","author":"Aroldi","year":"1997","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0244|cit244","unstructured":"Ponticelli C Steroid withdrawal in organ transplant recipients [abstract no: 0351] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sept 1; Rome, Italy 2000"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0245|cit245","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0041-1345(00)02298-3","article-title":"Steroid withdrawal in renal transplant recipients","volume":"33","author":"Ponticelli","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0246|cit246","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/s0272-6386(00)70051-5","article-title":"Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors","volume":"35","author":"Montagnino","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1399-0012.2009.01171.x","article-title":"Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral plus Rapamune: four-yr results of a randomized monocenter study","volume":"24","author":"Sandrini","year":"2010","journal-title":"Clinical Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0248|cit248","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1399-0012.2008.00890.x","article-title":"Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy","volume":"23","author":"Sandrini","year":"2009","journal-title":"Clinical Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0249|cit249","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.transproceed.2015.12.013","article-title":"Early steroid withdrawal in recipients of a kidney transplant from a living donor: experience of a single Mexican center","volume":"48","author":"Andrade-Sierra","year":"2016","journal-title":"Transplantation Proceedings"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0250|cit250","first-page":"322A","article-title":"Early steroids withdrawals improves hemodynamic profile and does not increase acute rejection risks in kidney transplant recipients [abstract no: TH-PO913]","volume":"22","author":"Andrade-Sierra","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0251|cit251","first-page":"673","article-title":"Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study","volume":"5","author":"Nematalla","year":"2007","journal-title":"Experimental & Clinical Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0252|cit252","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/00365591003649219","article-title":"Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study","volume":"44","author":"Gheith","year":"2010","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0253|cit253","first-page":"86","article-title":"Steroid avoidance immunosuppressive protocol: long term evaluation of prospective randomized study after live donor renal allotransplant [abstract: O-323]","volume":"22","author":"Nematalla","year":"2009","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0254|cit254","unstructured":"Nematalla AH Bakr MA Gheith OA Akl A EL Agroudy AE EL Shahawy M Steroid avoidance immunosuppression: long term evaluation in live donor renal allotransplant recipients [abstract no: P66] British Transplantation Society (BTS).11th Annual Congress; 2008 Apr 16-18; Glasgow, UK 2008"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005632.pub4-BIB0255|cit255","first-page":"iv263","article-title":"Steroid avoidance immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized controlled study single center experience (one year follow up) [abstract no: SP734]","volume":"21","author":"Nematalla","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0256|cit256","first-page":"157","article-title":"Steroid free immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized study (single center experience) [abstract no: PO-466]","volume":"18","author":"Nematalla","year":"2005","journal-title":"Transplant International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0257|cit257","first-page":"134","article-title":"Improving quality of life after steroid avoidance immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized controlled study single center experience (two year follow up) [abstract no: P163]","volume":"20","author":"Neamatalla","year":"2007","journal-title":"Transplant International"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD005632.pub4-BIB0258|cit258","first-page":"vi93","article-title":"Improving quality of life after steroid avoidance immunosuppression regimen in live donor renal allotransplant recipients - a prospective randomized controlled study single center experience (two year follow up) [abstract no: FP222]","volume":"22","author":"Neamatalla","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0259|cit259","first-page":"121","article-title":"Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study","volume":"9","author":"Gheith","year":"2011","journal-title":"Experimental & Clinical Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0260|cit260","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/s0041-1345(98)01439-0","article-title":"Long-term results of cyclosporine monotherapy in renal transplantation","volume":"30","author":"Kim","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD005632.pub4-BIB0261|cit261","first-page":"1985","article-title":"A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine\/prednisolone during the maintenance phase of immunosuppression","volume":"26","author":"Park","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD005632.pub4-BIB0262|cit262","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/s0041-1345(00)02778-0","article-title":"Preliminary results of a prospective randomized study of basiliximab in kidney transplantation","volume":"33","author":"Pisani","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005632.pub4-BIB0263|cit263","unstructured":"Coppelli A Buonomo O Iaria G Pisani F Pollicita S Rizzello A Preliminary results of a prospective randomized study of basiliximab and steroid withdrawal in kidney transplantation [abstract no: 1617] 2001 A Transplant Odyssey; 2001 Aug 20-23; Istanbul, Turkey 2001"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0264|cit264","first-page":"191","article-title":"Prospective, multicenter, randomized, open-label study of myfortic with steroid withdrawal vs myfortic with standard steroid regimen to prevent acute rejection in de novo kidney transplantation [abstract no: 136]","volume":"5","author":"Del Castillo","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005632.pub4-BIB0265|cit265","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1600-6143.2009.02767.x","article-title":"A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation","volume":"10","author":"Benfield","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD005632.pub4-BIB0266|cit266","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"McDonald","year":"2008","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0267|cit267","first-page":"418","article-title":"Increased incidence of PTLD in pediatric renal transplant recipients enrolled in a randomized controlled trial of steroid withdrawal: a study of the CCTPT [abstract no: 1028]","volume":"5","author":"McDonald","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD005632.pub4-BIB0268|cit268","first-page":"402","article-title":"A randomized controlled double-blind trial of steroid withdrawal in pediatric renal transplantation: a study of the Cooperative Clinical trials in pediatric transplantation (CCTPT) [abstract no: 966]","volume":"5","author":"Benfield","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0269|cit269","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/TP.0b013e31819b6d4a","article-title":"Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil","volume":"87","author":"H\u00f6cker","year":"2009","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD005632.pub4-BIB0270|cit270","first-page":"1876","article-title":"Prospective randomized trial on late steroid withdrawal in pediatric renal transplant recipients under CSA and MMF: 2-year data [abstract no: SAT-M-124]","volume":"24","author":"Weber","year":"2009","journal-title":"Pediatric Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD005632.pub4-BIB0271|cit271","first-page":"679A","article-title":"Late steroid withdrawal in pediatric renal transplant recipients under cyclosporin microemulsion and mycophenolate mofetil [abstract no: SA-PO2535]","volume":"19","author":"Weber","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005632.pub4-BIB0272|cit272","first-page":"1429","article-title":"Prospective randomized multicenter trial on withdrawal of steroids in pediatric renal transplant recipients with stable graft function on cyclosporin A (CsA) and mycophenolate mofetil (MMF) [abstract no: 240 (SY)]","volume":"22","author":"T\u00f6nshoff","year":"2007","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005632.pub4-BIB0273|cit273","first-page":"366","article-title":"Prospective randomized trial on late steroid withdrawal in pediatric renal transplant recipients under CsA and MMF: 2-year data [abstract no: 605]","volume":"9","author":"Hoecker","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0274|cit274","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ndt\/gfp506","article-title":"Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation","volume":"25","author":"H\u00f6cker","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0275|cit275","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00467-018-4069-1","article-title":"Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial","volume":"34","author":"Hocker","year":"2019","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005632.pub4-BIB0276|cit276","first-page":"134","article-title":"Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients-analysis of a prospective, randomized, controlled trial [abstract]","volume":"48","author":"Hocker","year":"2019","journal-title":"Nieren und Hochdruckkrankheiten"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005632.pub4-BIB0277|cit277","first-page":"4","article-title":"Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial [abstract no: 205.5]","volume":"23","author":"Hoecker","year":"2019","journal-title":"Pediatric Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005632.pub4-BIB0278|cit278","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000347024","article-title":"Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial","volume":"79","author":"Mericq","year":"2013","journal-title":"Hormone Research in Paediatrics"},{"issue":"10","key":"10.1002\/14651858.CD005632.pub4-BIB0279|cit279","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/jbmr.3761","article-title":"Glucocorticoids decrease longitudinal bone growth in pediatric kidney transplant recipients by stimulating the FGF23\/FGFR3 signaling pathway","volume":"34","author":"Delucchi","year":"2019","journal-title":"Journal of Bone & Mineral Research"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005632.pub4-BIB0280|cit280","first-page":"4A","article-title":"Effect of steroid withdrawal on growth, FGF23\/klotho and IGF-I\/GFBP3 axis in pediatric kidney transplantation [abstract no: TH-OR017]","volume":"22","author":"Michea","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005632.pub4-BIB0281|cit281","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/kjm2.12064","article-title":"Steroid withdrawal or avoidance is safe in high-risk kidney transplants: a systematic review and meta-analysis","volume":"35","author":"Song","year":"2019","journal-title":"Kaohsiung Journal of Medical Sciences"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:36:21Z","timestamp":1792992981000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005632.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":281,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005632.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}